Bandana Singh
Overview
Explore the profile of Bandana Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kashyap M, Roy S, Jaiswal S, Verma S, Srivastava S, Nigam A, et al.
Anticancer Agents Med Chem
. 2025 Jan;
PMID: 39754781
In women globally, breast cancer ranks as the second most frequent cause of cancer-related deaths, making up about 25% of female cancer cases, which is pretty standard in affluent countries....
2.
Singh B, Sasmal P, Taites A, Hazra S, Saha J
Org Lett
. 2024 Oct;
26(44):9558-9563.
PMID: 39453833
A strategy for activating azabicyclo[1.1.0]butane (ABB) with generated aza--quinone methide, promoted by HFIP, is reported. This unified activation, strain-release-driven N/C3-functionalization, features a new means to prepare functionalized azetidines from ABB....
3.
Peng Q, Arulsamy K, Lu Y, Wu H, Zhu B, Singh B, et al.
bioRxiv
. 2024 Sep;
PMID: 39282400
Background: Protein-tyrosine-phosphatase CD45 is exclusively expressed in all nucleated cells of the hematopoietic system but is rarely expressed in endothelial cells. Interestingly, our recent study indicated that activation of the...
4.
Zhu B, Gupta K, Cui K, Wang B, Malovichko M, Han X, et al.
bioRxiv
. 2024 Sep;
PMID: 39253478
Rationale: Low density cholesterol receptor (LDLR) in the liver is critical for the clearance of low-density lipoprotein cholesterol (LDL-C) in the blood. In atherogenic conditions, proprotein convertase subtilisin/kexin 9 (PCSK9)...
5.
Wang B, Cui K, Zhu B, Dong Y, Wang D, Singh B, et al.
bioRxiv
. 2024 Aug;
PMID: 39131381
Smooth muscle cells in major arteries play a crucial role in regulating coronary artery disease. Conversion of smooth muscle cells into other adverse cell types in the artery propels the...
6.
Singh B, Cui K, Eisa-Beygi S, Zhu B, Cowan D, Shi J, et al.
Vascul Pharmacol
. 2024 Apr;
155:107373.
PMID: 38658307
No abstract available.
7.
Singh B, Cui K, Eisa-Beygi S, Zhu B, Cowan D, Shi J, et al.
Vascul Pharmacol
. 2024 Mar;
155:107368.
PMID: 38548093
Atherosclerosis, a chronic systemic inflammatory condition, is implicated in most cardiovascular ischemic events. The pathophysiology of atherosclerosis involves various cell types and associated processes, including endothelial cell activation, monocyte recruitment,...
8.
Zhu B, Wu H, Li K, Eisa-Beygi S, Singh B, Bielenberg D, et al.
Vascul Pharmacol
. 2023 Dec;
154:107249.
PMID: 38070759
The prevalence of non-alcoholic fatty liver disease (NAFLD) and atherosclerosis remain high, which is primarily due to widespread adoption of a western diet and sedentary lifestyle. NAFLD, together with advanced...
9.
Jaiswal V, Mondal S, Singh B, Singh V, Saha J
Angew Chem Int Ed Engl
. 2023 May;
62(30):e202304471.
PMID: 37243932
Access to 1,3-functionalized azetidines through a diversity-oriented approach is highly sought-after for finding new applications in drug-discovery. To this goal, strain-release-driven functionalization of azabicyclo[1.1.0]-butane (ABB) has generated significant interest. Through...
10.
Kanack A, Schaefer J, Sridharan M, Splinter N, Kohlhagen M, Singh B, et al.
Blood
. 2023 Jan;
141(14):1772-1776.
PMID: 36626584
No abstract available.